In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Advanced Bionics

Executive Summary

Implantable electrostimulation devices.

You may also be interested in...

Alfred Mann: Boundless Innovator

An interview with Alfred Mann, one of the device industry's most remarkable innovators, whose extraordinary technological and commercial successes extend from cardiology to cochlear implants to neurostimulation, and who is now looking to succeed where others have failed with inhaled insulin.

Neuromodulation: Devices's Stimulating Growth Market

According to "Opportunities in Global Medical Devices and Diagnostics," a report recently published by Health Research International that forecasts growth rates in seven major clinical segments and 20 major technology segments, neuromodulation will experience the highest growth rate of all the top-tier segments over the next five years, in excess of 18%. The neuromodulation segment posted sales of approximately $1.7 billion in 2005 and will be worth almost $4 billion in 2010, HRI predicts.

Neuronetics Inc.

Neuronetics Inc. has developed a device for treating serious depression in pharmaco-resistant patients. The company believes that its repetitive Transcranial Magnetic Stimulation technology, delivered noninvasively in an outpatient setting, is free of the serious side effects that accompany antidepressant drugs; moreover that it will be more effective and much safer for patients than the only currently approved neuromodulation technology for depression: electroconvulsive therapy.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts